Related Experiment Video

Updated: Aug 12, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

Growth hormone deficiency

D Gordon1

  • 1University Department of Medicine, Royal Infirmary, Glasgow.

Scottish Medical Journal
|August 1, 1987
PubMed

Insights

Growth hormone deficiency is often relative, not absolute. A six-month growth hormone (GH) trial is recommended for slow-growing children to identify those who will benefit from treatment.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Child Development

Background:

  • Growth hormone deficiency (GHD) is not always absolute.
  • Conventional stimulation tests may miss children who could benefit from treatment.
  • Hypothalamic dysfunction is a common cause of GHD in children.

Purpose of the Study:

  • To evaluate the efficacy of growth hormone (GH) treatment in short, slow-growing children.
  • To determine optimal diagnostic and treatment strategies for GHD.
  • To identify patient groups that benefit from GH therapy.

Main Methods:

  • Accurate anthropomorphic measurements for slow-growing children (growth rate < 4 cm/yr).
  • Six-month therapeutic trial of human GH (hGH) for eligible children.
  • Assessment of treatment response in children with idiopathic GHD and secondary GHD (e.g., post-cranial irradiation).

Main Results:

  • Conventional tests may underestimate the need for GH treatment.
  • Frequent, divided doses of hGH are most efficacious.
  • GH-RH can be an alternative treatment for some patients.

Conclusions:

  • A trial of hGH is justified for all short children growing slowly.
  • Treatment with hGH can benefit children with Turner's syndrome and other short stature conditions.
  • Accurate measurements and individualized treatment approaches are crucial for managing GHD.

More Related Videos

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology09:48

Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology

Published on: February 25, 2022

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model05:32

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model

Published on: August 11, 2023

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...